Download PDF
Nuklearmedizin 1986; 25(06): 225-226
DOI: 10.1055/s-0038-1624347
Originalarbeiten — Original Articles
Schattauer GmbH

First Experiments on Radioimmunodetection with b-12-Monoclonal Antibody Fragments against Breast Cancer Antigen[*]

R. Fridrich
1   From the Department of Nuclear Medicine, University Hospital Basel, Switzerland
,
R. Andres
1   From the Department of Nuclear Medicine, University Hospital Basel, Switzerland
,
C. Stähli
1   From the Department of Nuclear Medicine, University Hospital Basel, Switzerland
,
H. R. Zenklusen
1   From the Department of Nuclear Medicine, University Hospital Basel, Switzerland
› Author Affiliations
Further Information

Publication History

Received: 30 June 1986

Publication Date:
20 January 2018 (online)

Also available at
    Permissions and Reprints

In 14 patients with breast cancer the results of radioimmunoscintigraphy with 123l-labeled b-12 monoclonal antibody fragments were correct in more than two thirds of the patients.

Zusammenfassung

Bei 14 Patienten mit Mammakarzinom zeigte die Radioimmunszintigraphie mit 123J markierten b-12 monoklonalen Antikörperfragmenten bei über zwei Drittel aller Patienten ein richtiges Ergebnis.

* Presented at the Symposion on “Monoclonal Antibodies in Nuclear Medicine” in Freiburg i.Br., May 1-3, 1986.


 

  • REFERENCES

  • 1 Bradwell A, Fairweather D, Dylles P, Keeling A. Limiting factors in the localization of tumours with radiolabeled antibodies. Immunology Today 1985; 06: 163-70.
    CrossrefSearch in Google Scholar
  • 2 Stähli C, Takacs B, Miggiano V, Staehelin T, Carmann H. Monoclonal antibodies against antigens on breast cancer cells. Experientia 1985; 41: 1377-81.
    CrossrefSearch in Google Scholar